New date for Annual General Meeting
Oncology Venture Sweden AB hereby announces that the new scheduled date for the Annual General Meeting is 8 May, 2017. Previously announced date was 12 April, 2017. For further information about Oncology Venture, please contact:Ulla Hald Buhl, COO and Chief IR & or Peter Buhl Jensen, CEOMobile: +45 21CommunicationsMobile: +45 2170 60 89 22E-mail:1049uhb@oncologyventure.com pbj@oncologyventure.com About Oncology Venture Sweden AB Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish